4
Changes in Ownership
Transcode Therapeutics, Inc. Filed Acc 0001104659-22-127083
Options or other derivatives
- Chief Technology Officer acquired 60,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Medarova Zdravka Chief Technology Officer | 2022-12-12 | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | D | ||
Loading xslF345X03/tm2232745-3_4seq1.xml…